Market Tracker

01/27 5:15pm ET

Synageva BioPharma Corp (NASDAQ:GEVA)

During the Trading Day
119.77 -1.15 / -0.95%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
119.77 0.00 / 0.00%
 
Volume: 6.5K

Today’s Trading

Previous close120.92
Today’s open119.42
Day’s range118.68 - 122.75
Volume324,260
Average volume (3 months)278,462
Market cap$4.5B
Dividend yield--
Data as of 3:59pm ET, 01/27/2015

Growth & Valuation

Earnings growth (last year)-78.95%
Earnings growth (this year)-72.84%
Earnings growth (next 5 years)+36.00%
Revenue growth (last year)-10.57%
P/E ratioNM
Price/Sales135.92
Price/Book8.65

Competitors

 Today’s
change
Today’s
% change
JUNOJuno Therapeutics In...+0.01+0.02%
CTLTCatalent Inc-0.13-0.46%
BLUEbluebird bio Inc-0.42-0.43%
XONIntrexon Corp+2.52+8.58%
Data as of 4:02pm ET, 01/27/2015

Financials

Next reporting dateMarch 9, 2015
EPS forecast (this quarter)-$1.71
Annual revenue (last year)$13.4M
Annual profit (last year)-$95.5M
Net profit margin-713.70%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Sanj K. Patel
Chief Operating Officer
Robert B. Bazemore
Corporate headquarters
Lexington, Massachusetts

Forecasts